Home/Publication/Qiming, LYFE & Sinovation to Automate Drug Development
Qiming, LYFE & Sinovation to Automate Drug Development 

10 Jan 2024

US$ 19.00

Qiming Venture Partners and LYFE Capital have co-led the US$26 million series A funding round of Shanghai Chemlex...

Price / article: US$19.00
OR existing subscriber
Related Publications

Keppel Ltd has raised an aggregate of around US$1.5 bn in new commitments for its two infrastructure funds and a ......

Vision Knight Capital has led the series C financing round of Panex WD International Group (Panex) for an ......

Connect With Us

We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.

Rest assured that your email address will not be shared, as we hate spams as much as you do.